Pharma Journalist -

Mangoceuticals has launched MangoRx Direct and PeachesRx Direct, new programs offering customers direct access to FDA-approved GLP-1 medications Zepbound (tirzepatide) and Wegovy…
Read More...

MeiraGTx Holdings plc has announced a broad strategic collaboration with Eli Lilly and Company focused on advancing gene therapies for ophthalmic diseases, including a groundbreaking…
Read More...

Insilico Medicine, a clinical-stage company pioneering generative AI-driven drug discovery, has announced a new research collaboration with Eli Lilly and Company to jointly develop…
Read More...

SanegeneBio, a clinical-stage biotechnology company focused on RNAi therapeutics, has entered a global research and licensing collaboration with Eli Lilly and Company to develop…
Read More...

Harbour BioMed and Evinova have announced a strategic collaboration to integrate artificial intelligence (AI) and digital technologies into biologics research and development. The…
Read More...

Novartis has announced the opening of a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, California — a major step in the company’s $23 billion,…
Read More...

Lyell Immunopharma, Inc., a late-stage clinical biotech company developing next-generation chimeric antigen receptor (CAR) T-cell therapies, has strengthened its solid tumor portfolio…
Read More...

Pelthos Therapeutics Inc. has acquired the U.S. commercialization rights to Xepi® (ozenoxacin) Cream, 1%, from Biofrontera Inc. and Ferrer Internacional S.A., expanding its dermatology…
Read More...

Alvotech and Advanz Pharma have announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisations for all four presentations of…
Read More...

Abzena, a leading end-to-end contract development and manufacturing organization (CDMO) for complex biologics and bioconjugates, has announced a strategic partnership with Mabqi, a…
Read More...